Large-scale causal analysis of gut microbiota and six common complications of diabetes: a mendelian randomization

Jiachen Wang1, Menghao Teng2, Ruoyang Feng1

  • 1Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, 710054, Xi'an, Shaanxi, China.

PubMed
Abstract

Insights

The gut microbiota (GM) is linked to diabetic complications like hypoglycemia and nephropathy. Specific bacterial classes, Bacteroidia and Verrucomicrobiae, show causal associations, offering new insights into diabetes management.

Area of Science:

  • Microbiome research
  • Metabolic disease research
  • Genetics

Background:

  • Diabetes mellitus is a complex metabolic disorder associated with numerous complications.
  • The gut microbiota (GM) plays a crucial role in host metabolism and immune function.
  • Understanding the interplay between GM and diabetic complications is vital for therapeutic advancements.

Purpose of the Study:

  • To investigate the causal associations between gut microbiota composition and six major diabetic complications.
  • To explore potential microbiome-mediated mechanisms underlying diabetic complications.

Main Methods:

  • Utilized two-sample Mendelian randomization (TSMR) analysis with data from the MiBioGen, Dutch Microbiome Project, and FinnGen consortia.
  • Employed inverse Mendelian randomization (MR) and multivariate MR (MVMR) to assess causality and account for confounding factors.
  • Conducted sensitivity analyses to ensure the robustness and stability of the findings.

Main Results:

  • Identified 61 suggestive causal markers linking gut microbiota and diabetic complications.
  • Found positive associations between the Bacteroidia class/Bacteroidales order and diabetic hypoglycemia.
  • Observed positive associations between the Verrucomicrobiae class/Verrucomicrobiales order and diabetic nephropathy.

Conclusions:

  • Established extensive causal relationships between specific gut microbiota taxa and diabetic complications.
  • These findings suggest novel microbiome-targeted therapeutic strategies for managing diabetes and its sequelae.
  • Highlights the potential of the gut microbiome as a key player in the pathogenesis of diabetic complications.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
533
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
927